Biocatalyst Market
Report ID: SQMIG15B2221
Report ID: SQMIG15B2221
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG15B2221 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
150
|Figures:
78
Global Biocatalyst Market size was valued at USD 643.5 Million in 2024 and is poised to grow from USD 690.35 Million in 2025 to USD 1211.2 Million by 2033, growing at a CAGR of 7.28% during the forecast period (2026-2033).
The international biocatalyst industry refers to enzymes and whole cell catalysts used to catalyze reactions during the synthesis of drugs, fine chemicals, and food processing. The significance of the biocatalyst market lies in the substitution of toxic reagents with environmentally friendly and selective processes resulting in a reduction in waste and energy consumption. Initially, the use of biocatalysts was restricted to niche uses, however, the development of genetically modified enzymes such as Novozyme-435 for biodiesel production in early 2000s established its feasibility. With advancements in protein engineering and high throughput screening, there have been additions to the catalog of biocatalysts, motivating chemical industries to integrate the concept in their routine production process due to the regulatory push towards sustainability and cost effectiveness in terms of low raw material costs.
Where firms opt for enzyme-mediated processes over petrochemical processes, their emissions are reduced. In turn, this fulfills the requirements of stringent environmental laws while enhancing the reputation of such companies. For instance, one of the biggest pharmaceuticals in the world opted for a lipase-catalyzed process to produce a chiral intermediate, which has reduced the use of solvents by 70% and reduced the time taken in manufacturing the product from weeks to days. Such a success promotes the development of enzyme discovery platforms and outsourcing facilities in the emerging markets.
How is AI-driven Automation Reshaping the Biocatalyst Market?
The emergence of automation powered by artificial intelligence is creating waves in the biocatalyst market through a combination of machine learning and enzyme engineering. Models that predict the behavior of enzymes allow for the design of catalysts with higher specificity and reduce the time of lab testing. Workflow automation facilitates the screening, scaling-up, and process optimization processes, helping firms meet pharmaceutical needs more quickly. Furthermore, this approach contributes to sustainability through efficient identification of pathways that reduce energy consumption and waste. Consequently, the development cycles are becoming more flexible, while biocatalysts are gaining popularity in different chemical markets. Another factor that drives the development of the industry is collaboration between firms that combine their skills in data science and traditional biotechnology.
Market snapshot - (2026-2033)
Global Market Size
USD 643.5 Million
Largest Segment
Enzymes
Fastest Growth
Microorganisms
Growth Rate
7.28% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global biocatalyst market is segmented by type, source, form, application, end use industry and region. Based on type, the market is segmented into Enzymes and Microorganisms. Based on source, the market is segmented into Microbial, Plant and Animal. Based on form, the market is segmented into Liquid, Powder and Immobilized. Based on application, the market is segmented into Pharmaceuticals, Food & Beverages, Biofuels, Detergents, Agriculture, Personal Care & Cosmetics and Others. Based on end use industry, the market is segmented into Healthcare & Pharmaceuticals, Food Processing, Chemical Industry, Energy & Biofuels, Agriculture and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The Enzymes Segments lead as they have high specificity and catalytic activity, which makes the reactions more accurate and thus limits by-product formation and purification requirements. The natural property of enzymes that makes them tunable via protein engineering is well suited for the demands of pharmaceutical industry as it requires consistent and pure active compounds. With a growing focus on green chemistry in the process of drug development, enzymes can be used as a tool which will not only reduce time but also satisfy regulatory requirements.
On the other side, the Microorganisms segments show the highest growth due to advances in synthetic biology which allow for developing custom strains for complex biosynthetic pathways. The possibility of producing enzymes in one host makes this process simpler and attracts companies looking for an effective scale-up process. Growing demand for sustainable bioprocesses increases interest in this segment.
The Plant segment has an upper hand due to the inherent capability of biocatalysts derived from plants, which have complicated post-translational modifications that are hard to produce through microorganisms. Such natural capability allows for production of chiral intermediates, necessary for sustainable production of medicines and cosmetics. Moreover, the renewable nature of these catalysts correlates with environmentally friendly marketing and traditional agricultural supply channels to make sure that there are enough raw materials available. Thus, these factors emphasize the importance of plant-based biocatalysts in the market.
On the other hand, Microbial segment rapidly grows due to genetic modification techniques allowing to obtain highly productive strains suitable for various industrial routes. The quick scaling of fermentation processes and ability to produce various types of bio-based products encourages investments and contributes to market penetration.
To get detailed segments analysis, Request a Free Sample Report
The North American market enjoys an established ecosystem for biotechnology, sound research infrastructure, and strong academia-industry collaboration. This region is home to clusters of some of the best enzyme manufacturers and specialty chemical manufacturers that contribute towards quick innovation and effective scale-up capabilities. Favorable regulatory environments promote the use of biocatalysis technologies, and investments into sustainable production processes create demand in pharma, fine chemicals, and food ingredients industries. Availability of a skilled labor force, state-of-the-art manufacturing infrastructure, and strong IP protection mechanisms only add on to its competitive advantages.
The Biocatalyst Market activities in the United States are driven by a vast number of research universities and hi-tech hubs which expedite enzyme identification and optimization processes. Venture capital investment drives startups which are based on developing new platforms for biocatalysis while big chemical companies use these technologies to improve their manufacturing process. The collaboration between governmental bodies and the private sector drives the implementation of lab achievements at a commercial scale.
Development of Biocatalyst Market in Canada has been driven by an enabling policy regime based on principles of green chemistry and sustainability of industries. Incentives provided at a provincial level have helped bring biotechnology companies to the region to set up research centers and collaborate with national research labs and universities. The strengths in areas of fermentation and enzyme engineering provide Canada with an edge in applications for the food sector and renewable chemicals industry.
The growth of Europe comes from its high focus on sustainable development as well as regulation encouraging low-impact production. The collaboration in enzyme design and use in research networks in Germany, UK and France helps speed up research and development efforts, while government initiatives encourage the implementation of biocatalysis technologies in the production of pharmaceuticals and fine chemicals. The area is fortunate to have a developed chemical industry that aims to substitute hazardous chemicals with more environmentally friendly ones, creating collaboration opportunities for academic institutions and big companies. environment for continued innovation and market growth across European markets.
Germany Biocatalyst Market trends have been driven by a strong chemical industry that focuses on process intensification using enzymes. Research centers in Germany work hand in hand with industries to develop enzymes and apply the same in the production of fine chemicals and pharmaceuticals. In addition, the government's drive for sustainability encourages companies to adopt biocatalysis processes, and an experienced engineering labor force facilitates successful scale-up.
The Biocatalyst Market in the UK is boosted through innovative clusters in biotechnology along with an enabling regulatory environment that promotes greener production systems. The excellent interaction between university laboratories and businesses ensures speedy development of enzymes used for drug development and speciality chemicals. Systems of funding geared towards sustainability technologies allow for experimentation and application, and the flourishing start-up environment allows scientific inventions to be turned into real-world products.
Market activities in France are taking place via strategic investments in bio-innovation centers, where academic research is paired with agro-chemicals and pharmaceutical companies. The focus on developing processes that utilize renewable feedstocks helps explore enzyme-catalyzed routes, and government programs are geared towards transferring technology and acquiring skills. This collaborative environment creates an opportunity to experiment with biocatalysis in niches and build up the French position in Europe.
Asia Pacific is making further progress in biocatalysts through the use of rapid industrialization as well as the increasing importance of sustainability in manufacturing activities. The combination of knowledge in Japan and South Korea in terms of precision engineering with biotechnology has made it possible for the creation of highly specific enzymes in pharmaceuticals, fine chemicals, and food products. Programs supported by the government that encourage the adoption of green technology as well as collaborative research efforts ensure technology transfer and commercialization.
Progress in Biocatalyst Market in Japan has been propelled by its history of excellence in process engineering as well as its expertise in enzyme science. Pharmaceutical companies work in collaboration with university labs to enhance the selectivity and stability of enzymes, allowing efficient synthesis. Support from national programs that promote green manufacturing provides funding for pilots, and a culture of perfectionism ensures quick optimization of processes, positioning Japan as an important player in the region’s development.
South Korean Biocatalysts Market Development is positively influenced by the coming together of sophisticated manufacturing facilities and a flourishing biotech industry. Government incentives are helping in the use of enzymatic processes in the production of chemicals and cosmetics, while research collaboration helps in enzyme identification and discovery. Technology integration and process scalability have been gaining importance to move from theory to practice, and hence South Korea’s growing position in the Asia Pacific biocatalysis industry is justified.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand for Sustainable Processes
The trend in businesses to use bio-catalytic processes is becoming more common due to the reduction in dependence on toxic chemicals, reduced energy usage, and less waste production. This sustainability approach helps fulfill the corporate objectives of minimizing environmental impact as well as complying with regulations, thus motivating companies to develop enzymes and integrate them in their processes. As companies opt for sustainable production processes, enzymes become more appealing and, as a result, the biocatalyst market continues to grow in the global market.
Advancements in Enzyme Engineering Technologies
New developments in protein engineering, directed evolution, and computational modeling help generate enzymes that have improved stability, activity, and substrate specificity. This helps create tailor-made biocatalysts for difficult reaction environments and varied feedstock, thus increasing their application scope across different industries. With these improvements, risks are minimized and time needed to develop new products is reduced, hence offering a better choice than chemical reactions. As a result, designing better enzymes contributes to increased market demand due to availability of possibilities to manufacture innovative products.
High Costs of Enzyme Development
Investment is needed in terms of special equipment, skilled staff, and testing when discovering, optimizing, and scaling up enzymes. These costs might prove too high for small companies and cause an unwillingness to use biocatalysis. Moreover, it takes time to test a biocatalyst and get all the necessary certificates, which also increases the costs. Thus, the process becomes expensive and might be prohibitive for companies located in areas where money availability is scarce and technologies are selected based on their costs.
Regulatory Uncertainty Across Regions
There are differences between the regulations regarding the use of biocatalysts from one nation to another in relation to how the safety, environmental, and labeling criteria need to be fulfilled. This disparity in regulations means that companies have to go through several processes to get approvals for their products. Sometimes, there may be unclear regulations which may create problems for the company during the development process of the biocatalyst product. Hence, uncertainty of regulations becomes a deterrent for the biocatalyst technology.
Request Free Customization of this report to help us to meet your business objectives.
The nature of competition for the global biocatalyst market is influenced by the fast deployment of sustainable biocatalysis and AI-based enzyme discovery, demonstrated by CPHI 2025 in which the world’s top enzyme producers collaborated with pharmaceutical companies to expedite scale-up processes. Technology platforms are being used by companies to shorten development cycles, but mergers and acquisitions in the past few years have increased competition in the field.
Sustainable Enzyme Design: There is a movement in the industry towards more sustainable production processes, which has led companies to develop enzymes that work in less severe environments and produce less waste. Scientists have combined the techniques of protein engineering with renewable raw materials to decrease energy use and avoid toxic solvents. The emphasis on sustainability does not only correspond to the responsibilities of businesses, but it also creates new business opportunities for collaboration with biotech firms, replacing conventional chemicals.
Digitalized Enzyme Discovery Pipelines: Innovations in artificial intelligence and high-throughput screening techniques are revolutionizing enzyme discovery and optimization. Firms are now harnessing the power of cloud-based technologies that combine genomics, AI models, and laboratory robotic systems to fast-track the process and minimize iterations. This technology revolution allows quick response to the growing demand for substrates, reduces the time-to-market for new biocatalysts, and helps smaller companies with limited research and development capabilities gain easy access.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means ofPrimary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis the key driving factor in the growth of the global market for biocatalysts is the increasing need for sustainable operations, thereby pushing manufacturers towards using greener enzyme-based processes in place of dangerous chemicals, whereas the second driving factor includes rapid developments in AI-powered enzyme engineering, which reduces time in product development and expands the scope of applications. The leading segment within the market is enzymes owing to their specificity and flexibility, while North America dominates geographically due to its advanced biotechnology industry and favorable regulation framework. High costs associated with enzyme development have become the major restraining factor for market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 643.5 Million |
| Market size value in 2033 | USD 1211.2 Million |
| Growth Rate | 7.28% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Biocatalyst Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biocatalyst Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biocatalyst Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biocatalyst Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Biocatalyst Market size was valued at USD 643.5 Million in 2024 and is poised to grow from USD 690.35 Million in 2025 to USD 1211.2 Million by 2033, growing at a CAGR of 7.28% during the forecast period (2026-2033).
The competitive landscape is shaped by rapid adoption of sustainable biocatalysis and AI‑driven enzyme discovery, highlighted at CPHI 2025 where leading enzyme manufacturers formed strategic partnerships with pharmaceutical firms to accelerate scale‑up. Companies are leveraging technology platforms to reduce development timelines, while recent M&A activity consolidates niche biocatalyst specialists, intensifying competition for market share. 'Novozymes A/S', 'DSM-Firmenich AG', 'DuPont de Nemours, Inc.', 'BASF SE', 'Advanced Enzyme Technologies Limited', 'Amano Enzyme Inc.', 'Codexis, Inc.', 'AB Enzymes GmbH (Associated British Foods plc)', 'Kerry Group plc', 'Chr. Hansen Holding A/S', 'Novus International, Inc. (Mitsui & Co., Ltd.)', 'Enzyme Development Corporation', 'Biocatalysts Ltd. (BRAIN Biotech AG)', 'BRAIN Biotech AG', 'Creative Enzymes', 'Sekisui Chemical Co., Ltd.', 'Aumgene Biosciences Pvt. Ltd.', 'Antozyme Biotech Pvt. Ltd.', 'Maps Enzymes Limited', 'Sunson Industry Group Co., Ltd.'
Companies are increasingly adopting biocatalytic routes because they reduce reliance on harsh chemicals, lower energy consumption, and generate fewer waste streams. This sustainability orientation aligns with corporate environmental goals and regulatory expectations, encouraging investment in enzyme development and process integration. As manufacturers prioritize greener production, biocatalysts become a preferred solution, driving market expansion through broader application across pharmaceuticals, fine chemicals, and food ingredients. The shift toward eco‑friendly manufacturing therefore creates a supportive environment for the global biocatalyst market and continual growth.
Sustainable Enzyme Design: The industry is shifting toward greener production pathways, prompting companies to engineer enzymes that operate under milder conditions and reduce waste. Researchers are integrating protein‑engineering tools with renewable feedstocks, enabling processes that lower energy consumption and eliminate hazardous solvents. This focus on sustainability not only aligns with corporate responsibility goals but also opens new partnerships with biotech firms seeking to replace traditional chemicals, thereby expanding the market reach of biocatalysts across pharmaceuticals, fine chemicals, and consumer goods sectors globally and sustainably.
Why does North America Dominate the Global Biocatalyst Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
